These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 2575177

  • 21. [Effect of anti-hypertensive treatment on plasma lipids and lipoproteins (author's transl)].
    Sauvanet JP, Rouffy J.
    Sem Hop; 1982 Mar 04; 58(9):563-8. PubMed ID: 6121378
    [Abstract] [Full Text] [Related]

  • 22. [Interference with lipid metabolism by various antihypertensive agents: facts and hypotheses].
    Rouffy J.
    Arch Mal Coeur Vaiss; 1987 Apr 04; 80 Spec No():43-6. PubMed ID: 2887148
    [Abstract] [Full Text] [Related]

  • 23. Effects of alpha 1-inhibition on lipid metabolism in the rat.
    Woodside WF, Swindell AC.
    J Cardiovasc Pharmacol; 1987 Apr 04; 10 Suppl 9():S27-34. PubMed ID: 2447438
    [Abstract] [Full Text] [Related]

  • 24. Lipid metabolism: implications of alpha 1-blockade.
    Rosenthal J.
    J Clin Pharmacol; 1993 Sep 04; 33(9):883-7. PubMed ID: 7901243
    [Abstract] [Full Text] [Related]

  • 25. The effects of adrenergic blockade on lipoproteins using the rat as an experimental model.
    Balasubramaniam S, Simons LA, Hickie JB, Chang S.
    Artery; 1990 Sep 04; 17(2):60-70. PubMed ID: 1968740
    [Abstract] [Full Text] [Related]

  • 26. [Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators].
    Jacob BG, Richter WO, Schwandt P.
    Fortschr Med; 1993 Mar 20; 111(8):126-9. PubMed ID: 8099558
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment.
    Rabkin SW.
    J Clin Pharmacol; 1993 Mar 20; 33(3):286-91. PubMed ID: 8096525
    [Abstract] [Full Text] [Related]

  • 28. The association between antihypertensive drug therapies and plasma lipid levels in the general population.
    Maitland-van der Zee AH, Klungel OH, Kloosterman JM, Seidell JC, Leufkens HG, de Boer A.
    J Hum Hypertens; 2001 Oct 20; 15(10):701-5. PubMed ID: 11607800
    [Abstract] [Full Text] [Related]

  • 29. Effects of antihypertensive drugs on lipid metabolism.
    Leren P.
    Clin Ther; 1987 Oct 20; 9(3):326-32. PubMed ID: 2886221
    [Abstract] [Full Text] [Related]

  • 30. Antihypertensive therapy and lipids. Evidence, mechanisms, and implications.
    Weinberger MH.
    Arch Intern Med; 1985 Jun 20; 145(6):1102-5. PubMed ID: 2860883
    [Abstract] [Full Text] [Related]

  • 31. Effects of oral contraceptives on lipid metabolism.
    Krauss RM.
    J Reprod Med; 1986 Jun 20; 31(6 Suppl):549-50. PubMed ID: 3723487
    [Abstract] [Full Text] [Related]

  • 32. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 20; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 33. The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.
    Ames RP.
    Drugs; 1986 Oct 20; 32(4):335-57. PubMed ID: 2877846
    [Abstract] [Full Text] [Related]

  • 34. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R, Hilliquin P.
    Contracept Fertil Sex (Paris); 1986 Jan 20; 14(1):81-7. PubMed ID: 12341243
    [Abstract] [Full Text] [Related]

  • 35. Hypertension and CHD risk: whither alpha-1 blockers?
    Pandit RB.
    Indian Heart J; 1996 Jan 20; 48(3):265-71. PubMed ID: 8755013
    [Abstract] [Full Text] [Related]

  • 36. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.
    Leren P.
    Am J Med; 1987 Jan 05; 82(1A):31-5. PubMed ID: 2879461
    [Abstract] [Full Text] [Related]

  • 37. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism.
    Nash DT.
    Clin Cardiol; 1990 Nov 05; 13(11):764-72. PubMed ID: 1980236
    [Abstract] [Full Text] [Related]

  • 38. Effect of antihypertensive agents on lipid metabolism.
    Cutler R.
    Am J Cardiol; 1983 Feb 24; 51(4):628-31. PubMed ID: 6131603
    [Abstract] [Full Text] [Related]

  • 39. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R.
    Artery; 1982 Feb 24; 10(4):266-85. PubMed ID: 7181672
    [Abstract] [Full Text] [Related]

  • 40. Antihypertensive agents and cardiovascular risk factors.
    Fodor JG.
    Clin Ther; 1986 Feb 24; 8(5):490-509. PubMed ID: 2876774
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.